Stocks
Cantel Medical (CMD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 81.6% | 67.9% | 65.4% | 32.8% | 95.8% | 72.6% | |||
| Changes by years, y/y, % | -28pp | -14pp | -2pp | -33pp | +63pp | -2.7% | |||
Cantel Medical. R&D/CAPEX, %
Cantel Medical. R&D/CAPEX, changes, pp
Cantel Medical (CMD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2021Q1 | 2020Q4 | 2021Q2 | 2021Q1 | 2021Q3 | LTM ? | |||
| R&D/CAPEX, % | 137.8% | 65.7% | 65.7% | 80.7% | 80.7% | 72.6% | ||
| Changes by years, y/y, % | -25pp | +21pp | -45pp | -83pp | -57pp | |||
| Changes by quarters, q/q, % | 0pp | -72pp | 0pp | +15pp | 0pp | |||
